BioNTech SE BNTX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 212.36M | -954.66M | -622.33M | -355.05M | -33.55M |
| Total Depreciation and Amortization | 382.48M | 309.50M | 141.92M | -38.07M | 145.20M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.60M | -33.38M | -89.62M | 1.02B | 29.81M |
| Change in Net Operating Assets | -751.84M | 690.75M | 77.45M | -264.72M | 771.26M |
| Cash from Operations | -149.40M | 12.21M | -492.57M | 360.29M | 912.73M |
| Capital Expenditure | -38.67M | -63.50M | -66.46M | -73.57M | -41.97M |
| Sale of Property, Plant, and Equipment | 1.73M | 3.95M | 1.87M | 698.50K | 3.39M |
| Cash Acquisitions | -36.60M | -- | -- | 308.25M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.00B | -56.87M | 3.17B | -3.41B | -1.04B |
| Cash from Investing | 929.67M | -116.42M | 3.10B | -3.17B | -1.08B |
| Total Debt Issued | 52.90M | 37.80M | 38.40M | 6.70M | -- |
| Total Debt Repaid | -11.20M | -17.10M | -12.00M | -19.00M | -11.50M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -274.30M | -129.20M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -2.00M | -- |
| Cash from Financing | -267.72M | -126.19M | 30.89M | -16.65M | -13.44M |
| Foreign Exchange rate Adjustments | 2.30M | -3.84M | -3.98M | 1.63M | -25.14M |
| Miscellaneous Cash Flow Adjustments | 14.39M | 3.49M | 13.34M | 13.39M | 1.17M |
| Net Change in Cash | 529.23M | -230.75M | 2.65B | -2.81B | -206.47M |